Abstract
Background
Cardiac magnetic resonance perfusion studies with adenosine stress have shown that splenic response can identify patients with inadequate pharmacologic stress. We investigate the incremental prognostic impact of splenic response ratio (SRR) in patients with normal Rubidium (Rb)-82 PET myocardial perfusion imaging (MPI).
Methods
Consecutive patients undergoing dipyridamole Rb-82 PET MPI for the evaluation of coronary artery disease were screened. Spleen and liver Rb-82 activity was measured and the SRR was calculated: SRR = (Spleen stress/Liver stress)/(Spleen rest/Liver rest). Major adverse cardiac events (MACE) were determined at 1 year of follow-up in patients with normal summed stress score and normal summed difference score.
Results
Of the 839 patients screened, the spleen was visualized in 703 (84%) of scans. There was significantly higher MACE observed in splenic non-responders vs splenic responders in both the normal SSS (7.8% vs 2.9%, P = .027) and the normal SDS groups (7.4% vs 2.2%, P = .014). In multivariate analysis in patients with normal SDS, splenic response was a significant, independent predictor of MACE (HR 2.97, 95% CI 1.10 to 8.04, P = .033).
Conclusions
SRR is a novel imaging metric to identify patients with sub-maximal vasodilator stress and an incremental prognostic marker in patients with normal SDS and SSS (Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT01128023).
Similar content being viewed by others
Abbreviations
- HD:
-
Hemodynamic
- CT:
-
Computed tomography
- MACE:
-
Major adverse cardiac events
- MFR:
-
Myocardial blood flow reserve
- MPI:
-
Myocardial perfusion imaging
- PET:
-
Positron emission tomography
- Rb:
-
Rubidium
- SDS:
-
Summed difference score
- SRR:
-
Splenic response ratio
- SSS:
-
Summed stress score
References
Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60:1828-37.
Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007;49:1052-8.
Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, Nixon J, et al. Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: A clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging. 2016;43:566-73.
Sandler MP, Kronenberg MW, Forman MB, Wolfe OH, Clanton JA, Partain CL. Dynamic fluctuations in blood and spleen radioactivity: Splenic contraction and relation to clinical radionuclide volume calculations. J Am Coll Cardiol. 1984;3:1205-11.
Hunter CR, Hill J, Ziadi MC, Beanlands RS, deKemp RA. Biodistribution and radiation dosimetry of (82)Rb at rest and during peak pharmacological stress in patients referred for myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2015;42:1032-42.
Bryant JAA, Harden S, George S, Shambrook J, Peebles C. Early clinical experience with “splenic switch-off” in adenosine stress CMR. J Cardiovasc Magn Reson. 2015;17:91.
Manisty C, Ripley DP, Herrey AS, Captur G, Wong TC, Petersen SE, et al. Splenic switch-off: A tool to assess stress adequacy in adenosine perfusion cardiac MR imaging. Radiology. 2015;276:732-40.
Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740-8.
Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction.[Erratum appears in Circulation 1998 Jul 14;98(2):190]. Circulation. 1998;97:535-43.
Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol. 2004;43:200-8.
Guntheroth WG, Mullins GL. Liver and spleen as venous reservoirs. Am J Physiol. 1963;204:35-41.
Mustafa SJ, Morrison RR, Teng B, Pelleg A. Adenosine receptors and the heart: Role in regulation of coronary blood flow and cardiac electrophysiology. Handb. 2009;193:161-88.
Fozard JR, Milavec-Krizman M. Contraction of the rat isolated spleen mediated by adenosine A1 receptor activation. Br J Pharmacol. 1993;109:1059-63.
Torres FS, Foppa M. Splenic switch-off for stress cardiovascular MR imaging and dipyridamole. Radiology. 2015;277:613-4.
Wang T, Mentzer RM Jr, Van Wylen DG. Interstitial adenosine with dipyridamole: Effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol. 1992;263(2 Pt 2):H552-8.
Senthamizhchelvan S, Bravo PE, Esaias C, Lodge MA, Merrill J, Hobbs RF, et al. Human biodistribution and radiation dosimetry of 82Rb. J Nucl Med. 2010;51(10):1592-9.
Conti A, Mariannini Y, Canuti E, Petrova T, Innocenti F, Zanobetti M, et al. Nuclear scan strategy and outcomes in chest pain patients value of stress testing with dipyridamole or adenosine. World J. 2014;13(2):94-101.
Disclosures
Karan Bami, Shrankhala Tewari, Fadi Guirguis, Linda Garrard, and Ann Guo have nothing to disclose. Terrence D. Ruddy has research grants from GE HealthCare and Advanced Accelerator Applications. Robert A. deKemp reports grants, consulting fees, and license revenues from Jubilant DraxImage and University of Ottawa Heart Institute (UOHI), outside the submitted work. Rob S. B. Beanlands reports grants and honoraria from Lantheus Medical Imaging, grants and honoraria from Jubilant DraxImage, and grants from GE Healthcare, outside the submitted work. Rob S. B. Beanlands is a Career Investigator supported but the Heart and Stroke Foundation of Ontario and a Tier 1 Research Chair supported by the University of Ottawa. Benjamin J. W. Chow holds the Saul and Edna Goldfarb Chair in Cardiac Imaging Research. He receives research support from CV Diagnostix and educational support from TeraRecon Inc. Girish Dwivedi was supported by a CIHR new investigator salary support award while at UOHI. Currently he is Wesfarmers Chair in Cardiology at University of Western Australia with an Adjunct Professor appointment at UOHI. The study was performed at UOHI.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarizes the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bami, K., Tewari, S., Guirguis, F. et al. Prognostic utility of splenic response ratio in dipyridamole PET myocardial perfusion imaging. J. Nucl. Cardiol. 26, 1888–1897 (2019). https://doi.org/10.1007/s12350-018-1269-9
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-018-1269-9